https://stock.noler.com/us/stock/gracell-biotechnologies-inc https://stock.noler.com/us/stock/gracell-biotechnologies-inc/13f-holdings-corporate-securities https://stock.noler.com/us/stock/gracell-biotechnologies-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/gracell-biotechnologies-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/gracell-biotechnologies-inc/accrued-rent-current https://stock.noler.com/us/stock/gracell-biotechnologies-inc/accumulated-depreciation https://stock.noler.com/us/stock/gracell-biotechnologies-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/gracell-biotechnologies-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/gracell-biotechnologies-inc/amended-reports https://stock.noler.com/us/stock/gracell-biotechnologies-inc/amount-of-restricted-net-assets-for-consolidated-and-unconsolidated-subsidiaries https://stock.noler.com/us/stock/gracell-biotechnologies-inc/aoci https://stock.noler.com/us/stock/gracell-biotechnologies-inc/auditor https://stock.noler.com/us/stock/gracell-biotechnologies-inc/authorized-dilution https://stock.noler.com/us/stock/gracell-biotechnologies-inc/basic-shares https://stock.noler.com/us/stock/gracell-biotechnologies-inc/beta https://stock.noler.com/us/stock/gracell-biotechnologies-inc/borrowing-debt https://stock.noler.com/us/stock/gracell-biotechnologies-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/gracell-biotechnologies-inc/capital-expenditures https://stock.noler.com/us/stock/gracell-biotechnologies-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/gracell-biotechnologies-inc/capital-leases-balance-sheet-assets-by-major-class-net https://stock.noler.com/us/stock/gracell-biotechnologies-inc/cash-and-equivalents https://stock.noler.com/us/stock/gracell-biotechnologies-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/gracell-biotechnologies-inc/cash-and-securities https://stock.noler.com/us/stock/gracell-biotechnologies-inc/cash-flow-breakdown https://stock.noler.com/us/stock/gracell-biotechnologies-inc/clinical-trials https://stock.noler.com/us/stock/gracell-biotechnologies-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/gracell-biotechnologies-inc/common-stock-value-outstanding https://stock.noler.com/us/stock/gracell-biotechnologies-inc/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/gracell-biotechnologies-inc/congressional-trades https://stock.noler.com/us/stock/gracell-biotechnologies-inc/convertible-securities-outstanding https://stock.noler.com/us/stock/gracell-biotechnologies-inc/convertible-securities-retired https://stock.noler.com/us/stock/gracell-biotechnologies-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/gracell-biotechnologies-inc/current-assets https://stock.noler.com/us/stock/gracell-biotechnologies-inc/current-liabilities https://stock.noler.com/us/stock/gracell-biotechnologies-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/gracell-biotechnologies-inc/customer-breakdown https://stock.noler.com/us/stock/gracell-biotechnologies-inc/debt-and-obligation-disclosures https://stock.noler.com/us/stock/gracell-biotechnologies-inc/debt-carrying-amount https://stock.noler.com/us/stock/gracell-biotechnologies-inc/deferred-costs-current https://stock.noler.com/us/stock/gracell-biotechnologies-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/gracell-biotechnologies-inc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/gracell-biotechnologies-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/gracell-biotechnologies-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/gracell-biotechnologies-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/gracell-biotechnologies-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/gracell-biotechnologies-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/gracell-biotechnologies-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/gracell-biotechnologies-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/gracell-biotechnologies-inc/depreciation https://stock.noler.com/us/stock/gracell-biotechnologies-inc/depreciation-and-amortization https://stock.noler.com/us/stock/gracell-biotechnologies-inc/diluted-shares https://stock.noler.com/us/stock/gracell-biotechnologies-inc/dividend-safety https://stock.noler.com/us/stock/gracell-biotechnologies-inc/due-to-related-parties-current https://stock.noler.com/us/stock/gracell-biotechnologies-inc/earnings-and-revenue-growth https://stock.noler.com/us/stock/gracell-biotechnologies-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/gracell-biotechnologies-inc/ebitda https://stock.noler.com/us/stock/gracell-biotechnologies-inc/eps https://stock.noler.com/us/stock/gracell-biotechnologies-inc/eps-basic https://stock.noler.com/us/stock/gracell-biotechnologies-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/gracell-biotechnologies-inc/executive-pay-measures https://stock.noler.com/us/stock/gracell-biotechnologies-inc/executive-pay-other https://stock.noler.com/us/stock/gracell-biotechnologies-inc/executive-pay-pvp https://stock.noler.com/us/stock/gracell-biotechnologies-inc/executive-pay-trading-arrangements https://stock.noler.com/us/stock/gracell-biotechnologies-inc/executive-salary-before-2006 https://stock.noler.com/us/stock/gracell-biotechnologies-inc/executive-salary-board https://stock.noler.com/us/stock/gracell-biotechnologies-inc/executive-salary-equity-awards https://stock.noler.com/us/stock/gracell-biotechnologies-inc/executive-salary-officers https://stock.noler.com/us/stock/gracell-biotechnologies-inc/executive-salary-other-compensation https://stock.noler.com/us/stock/gracell-biotechnologies-inc/executive-salary-other-mentions https://stock.noler.com/us/stock/gracell-biotechnologies-inc/executive-salary-pay-ratio https://stock.noler.com/us/stock/gracell-biotechnologies-inc/executive-salary-relatives https://stock.noler.com/us/stock/gracell-biotechnologies-inc/fails-to-deliver https://stock.noler.com/us/stock/gracell-biotechnologies-inc/financing-cash-flow https://stock.noler.com/us/stock/gracell-biotechnologies-inc/foreign-currency-exchange-rate-translation https://stock.noler.com/us/stock/gracell-biotechnologies-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/gracell-biotechnologies-inc/free-cash-flow https://stock.noler.com/us/stock/gracell-biotechnologies-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/gracell-biotechnologies-inc/general-and-administrative-expense https://stock.noler.com/us/stock/gracell-biotechnologies-inc/gross-margin https://stock.noler.com/us/stock/gracell-biotechnologies-inc/holders-breakdown https://stock.noler.com/us/stock/gracell-biotechnologies-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/gracell-biotechnologies-inc/income-tax https://stock.noler.com/us/stock/gracell-biotechnologies-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/gracell-biotechnologies-inc/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/gracell-biotechnologies-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/gracell-biotechnologies-inc/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/gracell-biotechnologies-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/gracell-biotechnologies-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/gracell-biotechnologies-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/gracell-biotechnologies-inc/insider-holders https://stock.noler.com/us/stock/gracell-biotechnologies-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/gracell-biotechnologies-inc/insider-transactions-other https://stock.noler.com/us/stock/gracell-biotechnologies-inc/insider-transactions-preferred https://stock.noler.com/us/stock/gracell-biotechnologies-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/gracell-biotechnologies-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/gracell-biotechnologies-inc/insider-transactions-swaps-forwards-futures https://stock.noler.com/us/stock/gracell-biotechnologies-inc/insider-transactions-warrants https://stock.noler.com/us/stock/gracell-biotechnologies-inc/institutional-holders https://stock.noler.com/us/stock/gracell-biotechnologies-inc/interest-expense https://stock.noler.com/us/stock/gracell-biotechnologies-inc/interest-paid-net https://stock.noler.com/us/stock/gracell-biotechnologies-inc/inventory-raw-materials https://stock.noler.com/us/stock/gracell-biotechnologies-inc/investing-cash-flow https://stock.noler.com/us/stock/gracell-biotechnologies-inc/investment-income-interest https://stock.noler.com/us/stock/gracell-biotechnologies-inc/iran-activity-notices https://stock.noler.com/us/stock/gracell-biotechnologies-inc/late-filing-notices https://stock.noler.com/us/stock/gracell-biotechnologies-inc/lawsuits-defendant https://stock.noler.com/us/stock/gracell-biotechnologies-inc/lawsuits-plaintiff https://stock.noler.com/us/stock/gracell-biotechnologies-inc/lease-and-rental-expense https://stock.noler.com/us/stock/gracell-biotechnologies-inc/lease-cost https://stock.noler.com/us/stock/gracell-biotechnologies-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/gracell-biotechnologies-inc/liabilities-assumed https://stock.noler.com/us/stock/gracell-biotechnologies-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/gracell-biotechnologies-inc/long-term-debt https://stock.noler.com/us/stock/gracell-biotechnologies-inc/long-term-loans-from-bank https://stock.noler.com/us/stock/gracell-biotechnologies-inc/major-holders https://stock.noler.com/us/stock/gracell-biotechnologies-inc/material-contracts https://stock.noler.com/us/stock/gracell-biotechnologies-inc/maturities-of-shortterm-investments https://stock.noler.com/us/stock/gracell-biotechnologies-inc/mentioned-by-other https://stock.noler.com/us/stock/gracell-biotechnologies-inc/minority-interest-decrease-from-redemptions https://stock.noler.com/us/stock/gracell-biotechnologies-inc/mutual-fund-holders https://stock.noler.com/us/stock/gracell-biotechnologies-inc/net-change-in-cash https://stock.noler.com/us/stock/gracell-biotechnologies-inc/net-income https://stock.noler.com/us/stock/gracell-biotechnologies-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/gracell-biotechnologies-inc/news https://stock.noler.com/us/stock/gracell-biotechnologies-inc/number-of-operating-segments https://stock.noler.com/us/stock/gracell-biotechnologies-inc/number-of-reportable-segments https://stock.noler.com/us/stock/gracell-biotechnologies-inc/obligation-breakdown https://stock.noler.com/us/stock/gracell-biotechnologies-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/gracell-biotechnologies-inc/oci-foreign-currency-translation-adjustment-tax https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-cash-flow https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-income https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-assets https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-cost https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-expense https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-liability https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-liability-current https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-payments https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-payments-due https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/gracell-biotechnologies-inc/operating-margin https://stock.noler.com/us/stock/gracell-biotechnologies-inc/other https://stock.noler.com/us/stock/gracell-biotechnologies-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/gracell-biotechnologies-inc/other-assets-miscellaneous-noncurrent https://stock.noler.com/us/stock/gracell-biotechnologies-inc/other-current-assets https://stock.noler.com/us/stock/gracell-biotechnologies-inc/other-income https://stock.noler.com/us/stock/gracell-biotechnologies-inc/other-noncurrent-assets https://stock.noler.com/us/stock/gracell-biotechnologies-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/gracell-biotechnologies-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/gracell-biotechnologies-inc/outstanding-bonds https://stock.noler.com/us/stock/gracell-biotechnologies-inc/outstanding-bonds-foreign https://stock.noler.com/us/stock/gracell-biotechnologies-inc/outstanding-bonds-matured https://stock.noler.com/us/stock/gracell-biotechnologies-inc/outstanding-bonds-matured-foreign https://stock.noler.com/us/stock/gracell-biotechnologies-inc/outstanding-bonds-matured-unclassified https://stock.noler.com/us/stock/gracell-biotechnologies-inc/outstanding-bonds-unclassified https://stock.noler.com/us/stock/gracell-biotechnologies-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/gracell-biotechnologies-inc/patents https://stock.noler.com/us/stock/gracell-biotechnologies-inc/patents-active https://stock.noler.com/us/stock/gracell-biotechnologies-inc/patents-expired https://stock.noler.com/us/stock/gracell-biotechnologies-inc/patents-pending https://stock.noler.com/us/stock/gracell-biotechnologies-inc/patents-rejected https://stock.noler.com/us/stock/gracell-biotechnologies-inc/payables-and-obligations https://stock.noler.com/us/stock/gracell-biotechnologies-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/gracell-biotechnologies-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/gracell-biotechnologies-inc/pb-ratio https://stock.noler.com/us/stock/gracell-biotechnologies-inc/pe-ratio https://stock.noler.com/us/stock/gracell-biotechnologies-inc/preferred-shares https://stock.noler.com/us/stock/gracell-biotechnologies-inc/preferred-shares-facts https://stock.noler.com/us/stock/gracell-biotechnologies-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/gracell-biotechnologies-inc/prepaid-expense-noncurrent https://stock.noler.com/us/stock/gracell-biotechnologies-inc/pretax-income https://stock.noler.com/us/stock/gracell-biotechnologies-inc/prices https://stock.noler.com/us/stock/gracell-biotechnologies-inc/proceeds-from-bank-debt https://stock.noler.com/us/stock/gracell-biotechnologies-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/gracell-biotechnologies-inc/proceeds-from-issuance-of-redeemable-convertible-preferred-stock https://stock.noler.com/us/stock/gracell-biotechnologies-inc/proceeds-from-repurchase-of-equity https://stock.noler.com/us/stock/gracell-biotechnologies-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/gracell-biotechnologies-inc/profit-loss https://stock.noler.com/us/stock/gracell-biotechnologies-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/gracell-biotechnologies-inc/property-plant-equipment https://stock.noler.com/us/stock/gracell-biotechnologies-inc/ps-ratio https://stock.noler.com/us/stock/gracell-biotechnologies-inc/quick-ratio https://stock.noler.com/us/stock/gracell-biotechnologies-inc/reddit https://stock.noler.com/us/stock/gracell-biotechnologies-inc/repayments-of-bank-debt https://stock.noler.com/us/stock/gracell-biotechnologies-inc/repayments-of-convertible-debt https://stock.noler.com/us/stock/gracell-biotechnologies-inc/research-and-development https://stock.noler.com/us/stock/gracell-biotechnologies-inc/retained-earnings https://stock.noler.com/us/stock/gracell-biotechnologies-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/gracell-biotechnologies-inc/sec-comment-letters https://stock.noler.com/us/stock/gracell-biotechnologies-inc/sec-enforcement-actions https://stock.noler.com/us/stock/gracell-biotechnologies-inc/sec-filings https://stock.noler.com/us/stock/gracell-biotechnologies-inc/share-buybacks https://stock.noler.com/us/stock/gracell-biotechnologies-inc/shareholder-equity https://stock.noler.com/us/stock/gracell-biotechnologies-inc/shareholders-equity https://stock.noler.com/us/stock/gracell-biotechnologies-inc/shares-authorized https://stock.noler.com/us/stock/gracell-biotechnologies-inc/shares-issued https://stock.noler.com/us/stock/gracell-biotechnologies-inc/shares-outstanding-analysis https://stock.noler.com/us/stock/gracell-biotechnologies-inc/short-interest https://stock.noler.com/us/stock/gracell-biotechnologies-inc/short-sale-volume https://stock.noler.com/us/stock/gracell-biotechnologies-inc/short-term-bank-loans-and-notes-payable https://stock.noler.com/us/stock/gracell-biotechnologies-inc/short-term-debt https://stock.noler.com/us/stock/gracell-biotechnologies-inc/short-term-investments https://stock.noler.com/us/stock/gracell-biotechnologies-inc/short-term-lease-cost https://stock.noler.com/us/stock/gracell-biotechnologies-inc/spending-and-interest-coverage https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-award-percentage-of-outstanding-stock-maximum https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-based-compensation https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-options-nonvested-options-forfeited-grant-date-fair-value https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-options-nonvested-options-forfeited-number-of-shares https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/gracell-biotechnologies-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/gracell-biotechnologies-inc/subsidiaries https://stock.noler.com/us/stock/gracell-biotechnologies-inc/supplier-breakdown https://stock.noler.com/us/stock/gracell-biotechnologies-inc/supplies https://stock.noler.com/us/stock/gracell-biotechnologies-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/gracell-biotechnologies-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/gracell-biotechnologies-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/gracell-biotechnologies-inc/temporary-equity-accretion-to-redemption-value-adjustment https://stock.noler.com/us/stock/gracell-biotechnologies-inc/temporary-equity-carrying-amount-including-portion-attributable-to-noncontrolling-interests https://stock.noler.com/us/stock/gracell-biotechnologies-inc/temporary-equity-dividends-adjustment https://stock.noler.com/us/stock/gracell-biotechnologies-inc/temporary-equity-shares-issued-value-new-issues https://stock.noler.com/us/stock/gracell-biotechnologies-inc/total-assets https://stock.noler.com/us/stock/gracell-biotechnologies-inc/total-liabilities https://stock.noler.com/us/stock/gracell-biotechnologies-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/gracell-biotechnologies-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/gracell-biotechnologies-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/gracell-biotechnologies-inc/value-added-tax-receivable-current https://stock.noler.com/us/stock/gracell-biotechnologies-inc/variable-lease-cost https://stock.noler.com/us/stock/gracell-biotechnologies-inc/voting-outcome https://stock.noler.com/us/stock/gracell-biotechnologies-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/gracell-biotechnologies-inc/youtube